Jane Street
RDHL

Jane Street’s Redhill Biopharma RDHL Stock Holding History

Jane Street’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,886
Closed -$17.3K – 10266
2024
Q2 		$17.3K Buy
+1,886
New +$20.9K ﹤0.01% 9053
2024
Q1 		– Sell
-3,472
Closed -$126K – 9927
2023
Q4 		$126K Buy
+3,472
New +$70.8K ﹤0.01% 8480
2023
Q1 		– Sell
-14
Closed -$2.02K – 9758
2022
Q4 		$2.02K Buy
+14
New +$6.06K ﹤0.01% 8934
2022
Q3 		– Sell
-11
Closed -$9K – 10317
2022
Q2 		$9K Sell
11
-17
-61% -$23.3K ﹤0.01% 9335
2022
Q1 		$72K Buy
28
+2
+8% +$4.74K ﹤0.01% 9574
2021
Q4 		$64K Sell
26
-1
-4% -$4K ﹤0.01% 9442
2021
Q3 		$123K Buy
27
+6
+29% +$40.7K ﹤0.01% 9181
2021
Q2 		$142K Buy
+21
New +$145K ﹤0.01% 9079
2020
Q2 		– Sell
-21
Closed -$95K – 7499
2020
Q1 		$95K Buy
+21
New +$105K ﹤0.01% 4955
2019
Q3 		– Sell
-59
Closed -$384K – 5628
2019
Q2 		$384K Buy
+59
New +$454K ﹤0.01% 3909
2017
Q2 		– Sell
-29
Closed -$276K – 4774
2017
Q1 		$276K Buy
+29
New +$290K ﹤0.01% 3531

Other funds holding RDHL

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Jane Street's RDHL Position: Q3 2024 in Review

Jane Street sold out of Redhill Biopharma (RDHL) in Q3 2024, closing a stake of 1,886 shares — an estimated $17.3K sold.

Jane Street first reported a position in RDHL in Q1 2017 and held it in 11 quarters. The position peaked at $384K in Q2 2019. 11 funds tracked by Wall St. Rank hold RDHL as of Q3 2024.

  • Jane Street reported no remaining Redhill Biopharma position as of Q3 2024 after selling out during the quarter.
  • Jane Street sold 1,886 Redhill Biopharma shares in Q3 2024, an estimated $17.3K.
  • Jane Street first reported a position in Redhill Biopharma in Q1 2017 and held it in 11 quarters.
  • Jane Street's Redhill Biopharma position peaked at $384K in Q2 2019.
  • 11 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.